PHAGES CARRY ORPHAN ANTITOXIN-LIKE ENZYMES TO NEUTRALIZE THE DARTG1 TOXIN-ANTITOXIN DEFENSE SYSTEM




KSI-301: antibody biopolymer conjugate in retinal disorders

KSI-301 is 15-fc0093dx a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of age-related macular degeneration (AMD), diabetic macular oedema (DME) and retinal vein occlusion (RVO).Preclinical and early clinical trials so far have shown promising results in retinal va

read more